Music listening interventions (MLI) have grown into a major subcategory in the world of complementary and alternative medicine research. These studies have led to an epistemic explosion in MLI clinical application across many disciplines. However, this body of research still contains a critical handicap that will limit its potential: dose and dosing. Inconsistencies in how much of an MLI a research participant receives in a study will continue to impact generalizability until an MLI's dose is both defined and incorporated into clinical trials. This brief paper explores MLI dose, and attempts to frame MLI dose research as a priority for all researchers who utilize this intervention in their studies.